期刊文献+

甲状腺滤泡源性肿瘤Ret、Mucin-1和Galectin-3蛋白表达及临床病理分析 被引量:4

下载PDF
导出
出处 《临床与实验病理学杂志》 CAS CSCD 北大核心 2006年第5期625-626,共2页 Chinese Journal of Clinical and Experimental Pathology
  • 相关文献

参考文献1

二级参考文献15

  • 1纪小龙,缪德标,李维华.无色素性恶性黑色素瘤的形态多样性[J].诊断病理学杂志,1995,2(4):201-202. 被引量:21
  • 2Chan JK,Tsang WY.Endocrine malignancies that may mimic benign lesions[J].Semin Diagn Pathol,1995,12(1 ):45-63.
  • 3Santoro M,Melillo RM,Carlomagno F,et al.Different mutations of the RET gene cause different human tumoral diseases[J].Biochimie,1999,81(4) :397-402.
  • 4Bieche I,Ruffet E,Zweibaum A,et al.MUC1 mucin gene,transcripts,and protein in adenomas and papillary carcinomas of the thyroid[J]. Thyroid ,1997,7(5):725-731.
  • 5Inohara H,Honjo Y,Yoshii T,et al.Expression of galectin-3 in fine-needle aspirates as a diagnostic marker differentiating benign from malignant thyroid neoplasms[J].Cancer,1999,85(11):2475-2484.
  • 6Eng C.RET proto-oncogene in the development of human cancer[J]. J Clin Oncol,1999,17(1):380-393.
  • 7Lam AK,Montone KT,Nolan KA,et al.Ret oncogene activation in papillary thyroid carcinoma:prevalence and implication on the histological parameters [J].Hum Pathol,1998,29(6):565-568.
  • 8Cinti R,Yin K,Ilc K,et al.RET rearrangements in papillary thyroid carcinomas and adenomas detected by interphase FISH[J].Cytogenet Cell Genet,2000,88(1-2):56-61.
  • 9Weiss M,Baruch A,Keydar I,et al.Preoperative diagnosis of thyroid papillary carcinoma by reverse transcriptase polymerase chain reaction of the MUC1 gene[J].Int J Cancer,1996,66(1):55-59.
  • 10Takao S,Keiichirou U,Suguru Y,et al.Mucin core protein expression in extrahepatic bile duct carcinoma is associated with metastases to the liver and poor prognosis[J].Cancer,1999,86(10):1966-1975.

共引文献9

同被引文献42

  • 1金文昊,李瑞永,金哲洙,李学哲.分化型甲状腺癌骨转移临床分析[J].中国肿瘤临床,2004,31(24):1389-1391. 被引量:9
  • 2嵇庆海,王玉龙,郭智.甲状腺癌诊治进展[J].肿瘤研究与临床,2006,18(3):214-216. 被引量:27
  • 3刘俊峰,鞠萍.TSHIRMA测定对甲状腺功能的诊断价值[J].实用医技杂志,2006,13(14):2428-2429. 被引量:5
  • 4李玉林.病理学[M].北京:人民卫生出版社,2008,1(7):150.
  • 5Kawachi K, Matsushita Y, Yonezawa S, et al. Galectin-3 expression in various thyroid neoplasms and its possible role in metastasis formation[J]. Hum Pathol, 2000, 31(4) : 428 -433.
  • 6Saggiorato E, Cappia S, De Giuli P, et al. Galectin-3 as a presurgical immunocytodiagnostic marker of minimally invasive follicular thyroid carcinoma[J]. J Clin Endoerinol Metab, 2001, 86( 11 ) : 5152 -5158.
  • 7Nascimento M C, Bisi H, Alves V A, et al. Differentional reactivity for galectin-3 in Hurthle cell adenomas and carcinomas [ J ]. Endocr Pathol, 2001, 12(3) : 275 -279.
  • 8Beesley M F, McLaren K M. Cytokeratin-19 and galectin-3 immunohistochemistry in the differential diagnosis of solitary thyroid nodules[J]. Histopathology, 2002, 41(3) : 236 -243.
  • 9Volante M, Bozzalla-Cassione F, Orlandi F, et al. Diagnostic role of galectin-3 in follicular thyroid tumors [ J ]. Virchows Arch, 2004, 444(4) : 309 -312.
  • 10Yoshii T, Fukumori T, Honjo Y, et al. Galectin-3 phosphorylation is required for its anti-apoptotic function and cell cycle arrest [J]. J Biol Chore, 2002, 277(9) : 6852 -6857.

引证文献4

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部